Velaglucerase alfa (VPRIV)

velaglucerase alfa · Shire (now Takeda)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Velaglucerase alfa (VPRIV), covering 2021-03-19 to 2021-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease [Phase 4]

See pricing